American Century Companies’s Applied Genetic Technologies Corporation AGTC Stock Holding History

American Century Companies’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-56,143	Closed	-$222K	–	1394
2017 Q3	$222K	Hold	56,143	–	–	﹤0.01%	1294
2017 Q2	$286K	Hold	56,143	–	–	﹤0.01%	1288
2017 Q1	$387K	Sell	56,143 -59,980	-52%	-$469K	﹤0.01%	1258
2016 Q4	$1.09M	Sell	116,123 -39,298	-25%	-$354K	﹤0.01%	1119
2016 Q3	$1.52M	Buy	155,421 +17,801	+13%	+$240K	﹤0.01%	1103
2016 Q2	$1.95M	Buy	137,620 +52,155	+61%	+$814K	﹤0.01%	1029
2016 Q1	$1.2M	Buy	85,465 +68,057	+391%	+$998K	﹤0.01%	1079
2015 Q4	$355K	Buy	+17,408	New	+$269K	﹤0.01%	1239

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

American Century Companies's AGTC Position: Q4 2017 in Review

American Century Companies sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2017, closing a stake of 56,143 shares — an estimated $222K sold.

American Century Companies first reported a position in AGTC in Q4 2015 and held it in 8 quarters. The position peaked at $1.95M in Q2 2016. 62 funds tracked by Wall St. Rank hold AGTC as of Q4 2017.

American Century Companies reported no remaining Applied Genetic Technologies Corporation position as of Q4 2017 after selling out during the quarter.
American Century Companies sold 56,143 Applied Genetic Technologies Corporation shares in Q4 2017, an estimated $222K.
American Century Companies first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 8 quarters.
American Century Companies's Applied Genetic Technologies Corporation position peaked at $1.95M in Q2 2016.
62 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2017.

Based on American Century Companies's 13F filing for Q4 2017, filed 2 Feb 2018.